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ABSTRACT
Background
The impact of influenza on morbidity and hospitalization in the tropics and subtropics is
poorly quantified. Uniquely, the Hong Kong Special Administrative Region has computerized
hospital discharge diagnoses on 95% of total bed days, allowing disease burden for a well-
defined population to be accurately assessed.
Methods and Findings
Influenza-associated morbidity and hospitalization was assessed by Poisson regression
models for weekly counts of hospitalizations in Hong Kong during 1996 to 2000, using
proportions of positive influenza types A (H1N1 and H3N2) and B isolations in specimens sent
for laboratory diagnosis as measures of influenza virus circulation. We adjusted for annual trend,
seasonality, temperature, and relative humidity, as well as respiratory syncytial virus circulation.
We found that influenza was significantly associated with hospitalization for acute respiratory
disease (International Classification of Diseases version 9 codes [ICD9] 460–466 and 480–487)
and its subcategory pneumonia and influenza (ICD9 480–487) for all age groups. The annual
rates of excess hospitalization per 100,000 population for acute respiratory diseases for the age
groups 0–14, 15–39, 40–64, 65–74, and 75þwere 163.3 (95% confidence interval [CI], 135–190),
6.0 (95% CI, 2.7–8.9), 14.9 (95% CI, 10.7–18.8), 83.8 (95% CI, 61.2–104.2), and 266 (95% CI, 198.7–
330.2), respectively. Influenza was also associated with hospitalization for cerebrovascular
disease (ICD9 430–438) for those aged over 75 y (55.4; 95% CI, 23.1–87.8); ischemic heart disease
(ICD9 410–414) for the age group 40–64 y (5.3; 95% CI, 0.5–9.5) and over 75 y (56.4; 95% CI,
21.1–93.4); and diabetes mellitus (ICD9 250) for all age groups older than 40 y.
Conclusions
Influenza has a major impact on hospitalization due to cardio-respiratory diseases as well as
on cerebrovascular disease, ischemic heart disease, and diabetes mellitus in the tropics and
subtropics. Better utilization of influenza vaccine during annual epidemics in the tropics will
enhance global vaccine production capacity and allow for better preparedness to meet the
surge in demand that is inevitable in confronting a pandemic.
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Inﬂuenza is a major cause of acute respiratory diseases.
Although the symptoms of inﬂuenza infection may be
relatively mild and self-limiting, its complications can lead
to hospitalization or death, especially in the older population
or in those with chronic health problems [1].
Excess mortality and hospitalization associated with inﬂu-
enza have been used to measure inﬂuenza severity for over a
century [2,3,4]. Two methods have previously been used to
derive such estimates. One is a comparative method, in which
the average numbers of deaths or hospital admissions during
the months assumed to have low or no inﬂuenza virus
circulation are deﬁned, followed by calculation of the excess
mortality or hospitalization by subtracting this baseline from
the observed numbers of deaths or hospital admissions
during inﬂuenza epidemics [5]. The other is the regression
method developed by Serﬂing, which sets a baseline for excess
numbers of events by ﬁtting a linear regression function to
the data of the period assumed to have low virus circulation,
after taking into consideration the confounding factors such
as seasonality and meteorological conditions [6]. The Serﬂing
method was used to assess impact on hospitalization, but only
in temperate countries where there are well-established and
clear seasonal patterns of inﬂuenza [7,8]. However, in tropical
and subtropical regions such as Hong Kong, there are no
well-deﬁned seasonal patterns and the Serﬂing method
cannot be readily applied. Using the comparative approach,
excess hospitalization from pneumonia and inﬂuenza due to
inﬂuenza A (H3N2) alone, and inﬂuenza A (H1N1) and
inﬂuenza B together, from 1969 to 1995 in the United States
was estimated to be 63.0 and 31.6 per 100,000 population,
respectively [5]. In general, adults aged over 65 y and children
younger than four y old are at higher risk of inﬂuenza-
associated hospitalization. For children in the United King-
dom and the United States, inﬂuenza was found to be
associated with excess hospitalization with annual rates of 41–
186 per 100,000 population for cardiopulmonary diseases in
the 1–14 age group [9], and 192–228 per 100,000 person-years
for acute respiratory diseases in the 5–17 age group [10]; and
was associated with a laboratory-conﬁrmed hospitalization
rate of 340–350 per 100,000 person-year in the less-than-2-y-
old age group [11]. In Hong Kong, the inﬂuenza-associated
excess hospitalization rates per 100,000 population for acute
respiratory diseases were 279–288 in children younger than 1
y; 209–218 in children between 1 y and 2 y old; 77–126
between 2 y and 5 y old; 21–57 between 5 y and 10 y old; and
8–16 between 10 y and 15 y old [12]. In a community-based
study, inﬂuenza was found to contribute substantially to
health resource utilization [13]. In addition, inﬂuenza virus A
(H3N2) has been demonstrated to result in more hospital-
izations or deaths than inﬂuenza A (H1N1) and B [14].
Researchers in temperate regions in Europe and North
America have used different strategies to quantify the disease
burden associated with inﬂuenza [1,15–17].
However, application of either comparative or Serﬂing
methods requires a well-deﬁned seasonal pattern. In tropical
and subtropical regions, inﬂuenza viruses circulate through-
out the whole year without a clearly demarcated and
predictable epidemic peak or period of virus activity. There-
fore, assessment based solely on the peak epidemic periods
will underestimate the disease burden of inﬂuenza [3]. As a
consequence, there are few reports on inﬂuenza-related
excess mortality or hospitalization in tropical and subtropical
regions. Recently, Poisson regression was used to estimate
inﬂuenza-related mortality in the United States [18] and by
our group in Hong Kong [19]. Instead of using the observed
numbers of deaths and excess deaths to deﬁne inﬂuenza
epidemics, we took advantage of available virology surveil-
lance data and calculated the excess mortality as the differ-
ence between the expected values when the observed
proportion of virus isolations is ﬁtted and the values when
no virus circulation is assumed. In this approach the errors
introduced by subjectively deﬁning periods of high and low
inﬂuenza virus activity can be minimized. This method allows
estimation of disease burden even in the absence of clearly
predictable and seasonal peaks of inﬂuenza activity [19]. This
approach was recently used to estimate inﬂuenza-associated
hospitalization in the United States [17] and in this study, in
Hong Kong.
The Hong Kong Special Administrative Region (SAR) is
situated in the tropics and has a subtropical climate with a
mean temperature of 248 C and mean relative humidity of
79%. It has a well-deﬁned population of 6.8 million, 95% of
whom are Chinese, living in a compact geographical area.
With most hospital admissions occurring in the public
hospital sector, Hong Kong provides a unique opportunity
to investigate inﬂuenza-associated hospitalization in a trop-
ical or subtropical setting.
Methods
Data
The public sector Hospital Authority manages over 95% of
hospital bed days in Hong Kong, and a central computerized
clinical management system captures discharges from all
patients [20]. We obtained weekly numbers of hospital
discharge diagnoses from the 14 acute hospitals during 1996
to 2000. The disease categories, retrieved from these records
were coded in the International Classiﬁcation of Diseases
version 9 codes (ICD9). They included acute respiratory
disease (ICD9 460–519) and subcategory pneumonia and
inﬂuenza (ICD9 480–487) for age groups 0–14, 15–39, 40–64,
65–74, and 75þ; cerebrovascular disease (ICD9 430–438),
ischemic heart disease (ICD9 410–414), and diabetes mellitus
(ICD9 250) for age groups 40–64, 65–74, and 75þ. Urinary
tract infection (ICD9 590–599) was also analyzed to serve as
an unrelated control disease category. The Microbiology
Laboratory of Queen Mary Hospital receives a mean of 6,249
(range 3,098 to 8,333) specimens for diagnosis of respiratory
infections annually, and given the compact geographical area
of the Hong Kong SAR, its data represent inﬂuenza virus
activity within the area under investigation. The proportion
of weekly total specimens positive for inﬂuenza A and B was
10.5% (range 0%–54.6%) (Figure 1) and for respiratory
syncytial virus (RSV) 8.8% (0%–31.5%). Weekly inﬂuenza and
RSV activity was assessed from the proportion of specimens
positive for inﬂuenza virus A and B (inﬂuenza AþB) and RSV.
Weekly mean temperature and relative humidity data were
obtained from the Hong Kong Observatory [21] .
Poisson Regression
We applied Poisson regression [18] (Protocol S1) to obtain
the core model, with the weekly counts of hospitalization for
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variates including weekly temperature and relative humidity,
as well as terms for trend, deﬁned by serial week numbers
(denoted by t), and seasonality, deﬁned by pairs of sin (2 p tk /
52) and cos (2 p t k/52) (where week t¼1, 2, ..., 260, and k is
the number of seasonal cycles per year to be determined by
spectral analysis) [22] (Table S1). Plots of partial autocorre-
lation for the residuals were examined for any discernible
patterns. Autoregression terms up to 9 wk were added until
all autocorrelations did not exceed the 95% conﬁdence
interval (CI) (around 6 0.1). The variables inﬂuenza A þ B
and RSV were entered into the core model to assess the
impact of inﬂuenza circulation with adjustment for RSV.
Delayed effects (lag effects) of inﬂuenza were assessed by
entering the variable measured at 0–3 wk preceding the
health outcome and selecting the one with the most
signiﬁcant effect.
Excess Hospitalization
The difference between the total observed and the total
expected hospitalizations when the proportion of inﬂuenza
viral isolations was assumed to be zero, was divided by the
total observed to yield the percentage of inﬂuenza-associated
hospitalization, i.e., percentage of excess hospitalization
attributable to inﬂuenza [23]. We then multiplied this
percentage of excess hospitalization by total hospitalizations
per year to obtain the ‘‘excess number’’ and divided it by the
population to obtain a rate of excess hospitalization per unit
of population to facilitate comparison with other published
studies. Results are expressed as excess percentages for
hospitalization and as rates per 100,000 populations for
inﬂuenza-associated hospitalization. The statistical packages
S-plus and Stata 8.2 (Stata Corporation, College Station,
Texas, United States) were used for analysis.
Results
Age-Specific Hospitalizations
Overall hospitalization rates per 100,000 population for
acute respiratory diseases and subcategory ‘‘inﬂuenza and
pneumonia’’ showed a J-shaped pattern with the lowest rate
in the 15–39 age group. For cerebrovascular disease, ischemic
heart disease, and diabetes the rates increased with increasing
age (Table 1).
Poisson Regression Core Models
The observed weekly counts of hospitalizations, particu-
larly for the two respiratory disease categories, closely
followed the weekly counts of hospitalizations ﬁtted from
the Poisson regression core model and co-varied with positive
inﬂuenza A and B proportion in specimens sent for
laboratory diagnosis (Figure 1).
Figure 1. Weekly Proportion of Influenza A and B Isolates and Weekly Number of Hospitalizations for Five Causes Observed and Fitted According to
Core Model with Control for Seasonality for All Ages
DOI: 10.1371/journal.pmed.0030121.g001
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Acute respiratory disease and subcategory pneumonia and
inﬂuenza were signiﬁcantly associated with inﬂuenza (p ,
0.001) in all the age groups (Table 2). For acute respiratory
disease and for pneumonia and inﬂuenza, the inﬂuenza-
associated excess hospitalization rates per 100,000 population
were lowest (6.0 and 2.9, respectively) in the 15–39 age group,
and highest (266.0 and 176.3, respectively) in the 75þ age
group (Table 2). Inﬂuenza was associated with 9.3% and
11.5% of total acute respiratory disease hospitalization in the
0–14 and 65- to 74-y age groups, respectively. Inﬂuenza was
also signiﬁcantly associated (p , 0.001) with excess hospital-
ization for cerebrovascular disease and ischemic heart disease
with rates of 55.4 and 56.4 per 100,000 population in those
aged 75 y or older. In those 40–64 y of age, inﬂuenza was
associated with 2.0% of all hospitalization for ischemic heart
disease. In addition, inﬂuenza was signiﬁcantly (p , 0.01)
associated with hospitalization for diabetes, with rates of 6.6,
23.9, and 53.3 per 100,000 population, respectively, in the age
groups 40–64, 65–74, and 75þ.
Considering all hospitalizations across all ages, inﬂuenza
was associated with 10.9% (95% CI, 9.5–12.1) of total
hospitalizations for acute respiratory diseases, 11.6% (95%
CI, 10.2–12.9) for pneumonia and inﬂuenza, 1.5% (95% CI,
0.6–2.5) for cerebrovascular disease, 1.8% (95% CI, 0.5–3.0)
for ischemic heart disease, and 3.5% (95% CI, 1.9–4.9) for
diabetes (Table 2, Figure 2). Inﬂuenza was not associated with
hospitalization due to urinary tract infection for any of the
age groups younger than 75, but there was an association in
those 75 y and older.
Discussion
Using the Poisson regression method we showed that
inﬂuenza is strongly associated with cardio-respiratory
hospitalization in all age groups in Hong Kong. We estimated
that inﬂuenza led to 29.3 excess pneumonia and inﬂuenza
hospitalizations per 100,000 populations of all ages, amount-
ing to 11.6% of all hospitalizations for this disease category. A
similar study in the United States during the period 1979 to
2001 found inﬂuenza associated with excess rates of pneumo-
nia and inﬂuenza hospitalization of 36.8 per 100,000
Table 1. Weekly Number of Total Hospitalization and Annual Total Hospitalization Rate per 100,000 Population in Hong Kong (1996–
2000)
Disease Age Mean SD Median Minimum Maximum Annual Hospitalization
Rate per
100,000 Population
Acute respiratory disease Ages 0–14 393.8 119.5 361.5 216 915 1,752.1
Ages 15–39 43.8 16.0 40.0 16 111 82.5
Ages 40–64 50.6 16.5 48.0 25 151 134.8
Ages 65–74 60.8 19.6 57.0 25 169 726.5
Ages 75þ 151.7 43.5 145.5 64 358 3,046.3
All ages 700.9 190.4 663.5 398 1,447 554.1
Pneumonia and influenza Ages 0–14 107.4 50.5 92.0 43 348 477.7
Ages 15–39 14.7 6.5 13.0 3 39 27.6
Ages 40–64 29.2 9.2 28.0 8 66 77.6
Ages 65–74 44.5 14.0 43.0 14 106 531.8
Ages 75þ 123.2 34.1 120.0 41 253 2,473.4
All ages 318.9 97.0 292.0 141 699 252.1
Cerebrovascular disease Ages 0–14 1.9 1.3 2.0 0 8 8.4
Ages 15–39 6.6 2.6 6.0 0 13 12.4
Ages 40–64 72.5 9.6 73.0 47 101 193.1
Ages 65–74 96.6 12.1 97.0 66 132 1,153.7
Ages 75þ 114.6 16.4 113.0 80 165 2,300.7
All ages 292.3 27.9 290.5 219 358 231.1
Ischemic heart disease Ages 0–14 0.2 0.5 0.0 0 2 0.9
Ages 15–39 4.3 2.0 4.0 0 11 8.0
Ages 40–64 98.8 14.2 100.0 50 139 263.1
Ages 65–74 105.2 14.9 106.0 60 138 1,256.7
Ages 75þ 87.4 15.0 86.0 56 134 1,754.6
All ages 295.9 34.6 298.0 184 387 233.9
Diabetes mellitus Ages 0–14 2.8 1.9 3.0 0 9 12.6
Ages 15–39 15.8 5.1 15.0 6 38 29.8
Ages 40–64 71.0 13.6 71.0 32 107 189.0
Ages 65–74 66.3 12.5 65.0 33 115 792.6
Ages 75þ 49.0 9.6 48.0 18 89 984.0
All ages 205.0 29.3 203.5 118 309 162.1
Urinary infection Ages 0–14 60.0 12.6 59.0 20 98 266.8
Ages 15–39 82.5 13.2 83.0 34 116 155.3
Ages 40–64 189.3 29.8 192.5 68 250 503.9
Ages 65–74 107.3 18.2 109.0 46 150 1,282.3
Ages 75þ 132.1 27.4 134.0 65 197 2,651.9
All ages 571.1 71.3 581.0 281 697 451.5
DOI: 10.1371/journal.pmed.0030121.t001
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all hospitalization for this diagnosis [17]. As expected, we
demonstrate that those aged þ75 y have the highest hospital-
ization rates and also the highest rate of inﬂuenza-associated
hospitalizations in all disease categories studied. The associ-
ation between inﬂuenza virus activity and hospitalization for
acute respiratory diseases was least in those aged 15–39 y, a
pattern also observed in the United States [17].
While the United States study [17] ﬁtted monthly data with
a single annual cycle, we chose the models that best ﬁtted
weekly data with changing patterns of seasonality year by
year. A variable seasonal pattern is common in warm
climates, a factor not usually allowed for in most other
studies. McBean and Hebert [24] analyzed weekly hospital
admissions of insurance beneﬁciaries in the United States
and reported that inﬂuenza accounted for an extra 9.8% of
pneumonia and inﬂuenza hospitalizations per year in the
American population aged 65 y and over, compared to our
estimate of 7.7% for Hong Kong (Table S2). We simulated
their analysis by changing their assumed seasonality of one
cycle per year into two cycles per year since Hong Kong has
two inﬂuenza peak seasons almost every year. Our results are
close to their estimates, with an excess inﬂuenza-related
hospitalization risk of 8.7% for pneumonia and inﬂuenza. We
also applied their model to our datasets of hospital
admissions for acute respiratory disease, cerebrovascular
disease, ischemic heart disease, and diabetes and found all
the excess hospitalization estimates to be similar to the
estimates based on our model, except for diabetes (1.4% for
McBean’s versus 3.8% for our model) (Table S2). In addition
to the United States studies, one in the Netherlands [16] using
Table 2. Influenza-Associated Excess Hospitalizations in 1996–2000 after Adjustment for Co-Variates Including Respiratory Syncytial
Virus (1996–2000)
Disease Age Lag (wk) Hospitalizations per Year (95% CI) p-Value
Excess (%) Excess Numbers Excess Numbers per 100,000 Population
Acute respiratory disease Age 0–14 0 9.3 (7.7, 10.8) 1,909 (1,581, 2,217) 163.3 (135.2, 189.7) , 0.001
Age15–39 0 7.2 (3.3, 10.8) 164 (75, 247) 6.0 (2.7, 8.9) 0.001
Age 40–64 1 11.0 (7.9, 13.9) 291 (209, 367) 14.9 (10.7, 18.8) , 0.001
Age 65–74 1 11.5 (8.4, 14.3) 365 (266, 454) 83.8 (61.2, 104.2) , 0.001
Age 75þ 0 8.7 (6.5, 10.8) 689 (515, 855) 266.0 (198.7, 330.2) , 0.001
All ages 0 10.9 (9.5, 12.1) 3,984 (3,472, 4,422) 60.6 (52.8, 67.2) , 0.001
Pneumonia and influenza Age 0–14 1 14.7 (11.8, 17.4) 822 (660, 973) 70.4 (56.5, 83.3) , 0.001
Age15–39 1 10.5 (6.1, 14.4) 80 (47, 110) 2.9 (1.7, 4.0) , 0.001
Age 40–64 1 8.7 (5.0, 12.1) 132 (76, 184) 6.8 (3.9, 9.4) , 0.001
Age 65–74 1 11.0 (8.1, 13.8) 256 (188, 321) 58.7 (43.3, 73.7) , 0.001
Age 75þ 0 7.1 (4.8, 9.3) 457 (309, 598) 176.3 (119.2, 231.0) , 0.001
All ages 1 11.6 (10.2, 12.9) 1,930 (1,697, 2,146) 29.3 (25.8, 32.6) , 0.001
Cerebrovascular disease Age 40–64 0 0.8 ( 0.8, 2.4) 30 ( 30, 91) 1.6 ( 1.6, 4.7) 0.334
Age 65–74 0 1.4 (0.0, 2.9) 71 (0, 146) 16.2 (0.0, 33.6) 0.053
Age 75þ 0 2.4 (1.0, 3.8) 144 (60, 227) 55.4 (23.1, 87.8) 0.001
All ages 0 1.5 (0.6, 2.5) 229 (92, 381) 3.5 (1.4, 5.8) 0.001
Ischemic heart disease Age 40–64 3 2.0 (0.2, 3.6) 103 (10, 186) 5.3 (0.5, 9.5) 0.028
Age 65–74 0 0.8 ( 0.8, 2.4) 44 ( 44, 132) 10.1 ( 10.1, 30.2) 0.337
Age 75þ 1 3.2 (1.2, 5.3) 146 (55, 242) 56.4 (21.1, 93.4) 0.002
All ages 3 1.8 (0.5, 3.0) 278 (77, 463) 4.2 (1.2, 7.0) 0.007
Diabetes mellitus Age 40–64 3 3.5 (1.4, 5.5) 130 (52, 204) 6.6 (2.7, 10.4) 0.001
Age 65–74 2 3.0 (0.9, 5.1) 104 (31, 177) 23.9 (7.2, 40.6) 0.007
Age 75þ 0 5.4 (3.1, 7.8) 138 (79, 199) 53.3 (30.6, 77.0) , 0.001
All ages 3 3.5 (1.9, 4.9) 375 (203, 524) 5.7 (3.1, 8.0) , 0.001
Urinary infection Age 0–14 3 2.1 ( 0.3, 4.4) 66 ( 9, 138) 5.6 ( 0.8, 11.8) 0.078
Age15–39 3 0.9 ( 1.1, 2.8) 39 ( 47, 121) 1.4 ( 1.7, 4.4) 0.374
Age 40–64 0  0.7 ( 2.6, 1.3)  69 ( 257, 128)  3.5 ( 13.1, 6.6) 0.510
Age 65–74 0 0.3 ( 1.6, 2.2) 17 ( 90, 123) 3.9 ( 20.6, 28.3) 0.793
Age 75þ 0 2.1 (0.8, 3.5) 145 (55, 241) 55.8 (21.3, 93.0) 0.003
All ages 3 0.8 ( 0.5, 2.2) 238 ( 149, 655) 3.6 ( 2.3, 10.0) 0.224
DOI: 10.1371/journal.pmed.0030121.t002
Figure 2. Percentage of Excess Hospitalizations Associated with
Influenza at Different Ages
ARD, acute respiratory diseases; P and I, pneumonia and influenza; CV,
cerebrovascular disease; IHD, ischemic heart disease; DM, diabetes
mellitus.
DOI: 10.1371/journal.pmed.0030121.g002
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Influenza-Associated HospitalizationPoisson regression on monthly data, showed signiﬁcant excess
hospitalization only for ‘‘pneumonia and inﬂuenza’’ with
rates per 100,000 in the 65þ age group of 38–175 (in low and
high risk groups), similar to those from this study and one
United States study [17] of 97 and 37, respectively. Our model
is better able to adjust for confounding due to irregular
seasonal patterns, and differences between our estimates and
those in the United States may also be explained by
differences in the models used [12]. We have evaluated the
ﬁtness of core models to the original data through plotting
partial autocorrelation function (Figure S1) and thereby
avoid the criticism leveled at previous studies about the lack
of proof for model validity [25]. A further strength is that in
our estimation for the excess hospitalization rates, we chose
the most signiﬁcant effect (i.e., with smallest p-value) within a
lag period of 0–3 wk. This method allows us to estimate the
effect for infection that may occur one to several weeks after
exposure to viruses, or from admissions which may be delayed
one to several weeks after infection. Selection of the most
signiﬁcant effect estimate during a lag period of several days
or weeks is widely used in health effects of air pollution
studies [26].
In addition to the marked increase in hospitalizations due
to pneumonia and inﬂuenza, which would be expected to
show an association with inﬂuenza virus activity, our results
also show that inﬂuenza is associated with excess hospital
admissions for other chronic diseases such as cerebrovascular
disease, ischemic heart disease, and diabetes. Effects of
inﬂuenza on cerebrovascular and ischemic heart disease
may be partly explained by the acute pathophysiological
responses triggered by inﬂuenza, which include changes in
circulating clotting factors, platelet aggregation, and lysis,
concentrations of inﬂammatory-response proteins, and alter-
nations in cytokine concentrations [27,28], which may
enhance thrombotic tendencies, impair vasodilation, or even
lead to endothelial injury [29]. Acute respiratory tract
infection is reportedly associated with an increased risk of
myocardial infarction and stroke [30]. We ﬁnd that excess
inﬂuenza-related hospitalizations, both for cerebrovascular
disease and for ischemic heart disease, were statistically
signiﬁcant in those older than 65 y (Table S2).
Hospitalization for diabetes mellitus was associated with
inﬂuenza in those older than 40 y (Table 2). Impaired immune
responses in diabetic patients might predispose to increased
direct and indirect effects of inﬂuenza, including bacterial
secondary infection, and thereby lead to increased inﬂuenza-
related morbidity and mortality [31]. Also, inﬂuenza and its
complications may destabilize the health and glycemic
control of chronically ill patients with diabetes so that they
may be hospitalized for a range of diabetes-related compli-
cations that may or may not be overtly related to inﬂuenza.
Our diabetic inpatients also had a higher case fatality ratio
during inﬂuenza epidemic periods than the baseline (4.1%
versus 3.3%, p value , 0.001) (unpublished data). So it is likely
that protection against inﬂuenza could contribute to the
reduction of both hospitalization and mortality in patients
with diabetes [32].
Overall, inﬂuenza was speciﬁcally related to the excess risk
of hospitalization with cardio-respiratory conditions, but not
with urinary tract infection, which served as a control disease
in this analysis. This suggests that the elderly who are a higher
risk group for cardio-respiratory disease would beneﬁt from
an inﬂuenza prevention program. However, in the 75þ age
group, inﬂuenza was signiﬁcantly associated with a discharge
diagnosis of urinary tract infection. This may be because
clinical presentation of infections in the elderly is often
atypical and non-speciﬁc, resulting in an imprecise ﬁnal
clinical diagnosis. Furthermore, older persons are more likely
to be admitted with multiple diseases. The probability that
patients with principal diagnosis of urinary tract infection
had co-morbidity coded as pneumonia and inﬂuenza,
cerebrovascular disease, ischemic heart disease, and diabetes
mellitus increased with age and was 0.76%, 8.69%, 7.32%, and
7.20%, respectively, for 75þ comparing with 0.27%, 3.79%,
3.42%, and 6.70%, respectively, for the 65–74 age group
(unpublished data).
The lack of convincing data of the clinical disease burden
of inﬂuenza in warm climate countries has led to the under-
utilization of inﬂuenza vaccine in the tropics [33]. For
example, while Hong Kong has a higher per capita gross
domestic product than Australia or New Zealand, the
inﬂuenza vaccine utilization in these three regions and
countries is respectively 28, 183, and 171 per 1,000
population in the year 2000, respectively [33]. The low
vaccine uptake may also reﬂect inadequate reimbursement
of the vaccine costs, the need for yearly vaccination, a
perceived low efﬁcacy, and fear of the relatively frequent,
albeit mild, side-effects [34]. A previous study in children
using a comparative approach demonstrated that inﬂuenza-
associated hospitalization rates in Hong Kong were compa-
rable to those in the United States [12]. In another recent
study in Hong Kong, the seasons were arbitrarily deﬁned and
adjustment was based on models that did not recognize that
count data should follow a Poisson distribution [35].
Our analysis using Poisson regression modeling of weekly
data demonstrates an approach for assessment of disease
impact of inﬂuenza in tropical and subtropical regions and
shows that it is possible to estimate inﬂuenza disease burden
in tropical regions with varying seasonal patterns of virus
activity. The Poisson regression modeling method provides
estimates that are robust to potential confounding effects,
which may arise from uncontrolled personal factors, such as
smoking status, and chronic co-morbidity [26]. This method-
ology correlates inﬂuenza virus activity with the residual
variation remaining after subtracting the underlying seasonal
variation in disease morbidity. However, some of the seasonal
variation in disease morbidity may also be contributed by
inﬂuenza, and this component is not captured by this type of
analysis. Thus, the estimates derived from our analysis is a
conservative one, and very likely to underestimate the true
impact of inﬂuenza on hospitalization. Ideally, an approach
that can also capture the seasonal variation associated with
inﬂuenza virus circulation is needed.
Our results provide evidence for the identiﬁcation of high
risk groups in tropical and subtropical settings who would
most beneﬁt from inﬂuenza vaccination. This is also the ﬁrst
study showing that circulation of inﬂuenza viruses is related
to hospitalization for diabetes mellitus supporting the argu-
ment that inﬂuenza vaccination may prevent hospitalization
for persons with this chronic problem. Increased morbidity
and mortality for diabetes during inﬂuenza epidemics have
long been recognized [36], but we assessed the excess
hospitalization rates due to yearly inﬂuenza virus circulation
rather than epidemics alone.
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Influenza-Associated HospitalizationAlthough a recent study has cast doubt on the extent of
protective efﬁcacy of vaccination in the elderly [7], those
ﬁndings do not detract from the overall consensus that
vaccination remains strongly recommended for protecting
the elderly and others at high risk from the adverse effects of
inﬂuenza [37]. Our ﬁndings emphasize that the disease
burden associated with inﬂuenza encompasses not just acute
respiratory diseases, but also cerebrovascular disease, ische-
mic heart disease, and diabetes mellitus. Vaccination for
inﬂuenza is reported to result in a reduction in hospital-
ization for respiratory or chronic heart disease greater for
those aged 65–79, than for those older than 80 [38], and also
for cardiac disease, cerebrovascular disease, and for pneumo-
nia and inﬂuenza [29] in the 65þ age group. According to a
meta-analysis [39], the pooled estimate of vaccine efﬁcacy in
persons aged 65 y and older, in terms of relative risk
reduction, was 0.27 (95% CI, 0.21–0.33) for preventing
hospitalizations for pneumonia and inﬂuenza, 0.22 (95% CI,
0.15–0.28) for respiratory diseases, and 0.24 (95% CI, 0.18–
0.30) for cardiac diseases. In this age group, the overall
hospitalization rates per 1,000 populations were 12 for
pneumonia and inﬂuenza, 68 for respiratory diseases, and
65 for cardiovascular diseases (derived from data in Table 1).
Assuming that these hospitalization rates can approximate
the expected hospitalization rates in the unvaccinated
population, the number needed to treat [40,41] to prevent a
hospitalization was estimated to be 311 (95% CI, 255–401) for
pneumonia and inﬂuenza, 71 (95% CI, 55–105) for respira-
tory diseases, and 68 (95% CI, 54–91) for cardiovascular
diseases. However, these estimates of the number needed to
treat tend to be conservative, since we use the hospitalization
rates of the general population that are likely lower than
those of unvaccinated groups. A further cost-beneﬁt analysis
based on our data may provide an assessment of the social
costs of this disease in Hong Kong and the total value of the
beneﬁts that may accrue from a vaccination program.
Hong Kong may not be representative of all tropical
regions in the demographics of health and sickness, in
patterns of morbidity and mortality, and in socio-economic
terms. However, it is pertinent to note that the increasing
urbanization and the growth of mega-cities is a rapidly
increasing global trend and these developments are occurring
in tropical regions as well. As such, the experience of Hong
Kong is relevant to the tropics and subtropics in general.
Better utilization of inﬂuenza vaccine during annual epi-
demics will enhance local, regional, and global vaccine
production capacity and also infrastructure for vaccine
delivery [42]. Therefore, in addition to a direct beneﬁt
reduction of inﬂuenza-associated hospitalization, the greater
utilization of inﬂuenza vaccines during inter-pandemic
periods in the tropics will lead to better access to vaccine
supplies when confronting a future pandemic.
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Patient Summary
Background. Influenza is a very common illness. It can sometimes be
serious—for example, in the elderly—and it adds to the costs of health
care. Studies in developed countries have shown that both death rates
and the number of people admitted to the hospital rise during seasonal
influenza outbreaks. These studies have made it possible to calculate the
‘‘disease burden’’ of influenza. So far, however, little has been known
about the impact influenza has on people in tropical and subtropical
countries. It is a difficult issue to study, partly because there is usually no
clearly established seasonal pattern of influenza in these countries.
Why Was This Study Done? The Hong Kong Special Administrative
Region in China (population 6.8 million) has a subtropical climate.
Ninety-five percent of the people admitted to the hospital go to public-
sector hospitals, which have a central computerised system where
clinical records are kept on all patients. This makes Hong Kong an
excellent place to study the impact influenza has on a subtropical city.
What Did the Researchers Do and Find? The researchers obtained
information on patients admitted to hospitals in Hong Kong during
1996–2000. In order to analyze the information, they developed an
appropriate statistical technique that allowed for such factors as
variations in temperature and humidity. They found that during
influenza outbreaks hospital admissions increased, not only for
respiratory diseases (including pneumonia), but also for heart problems,
stroke, and diabetes. The increases were most noticeable for older
people. Overall, influenza was responsible for 10.9% of admissions for
acute respiratory diseases, 1.5% of admissions for stroke, 1.8% for heart
attacks, and 3.5% for diabetes. These figures are comparable to what has
been found in developed countries outside the tropics.
What Does This Mean? On the basis of this study, influenza seems to
have a bigger impact on subtropical and tropical countries than has been
recognizeduntilnow.Vaccinationprogramsforpeopleathighrisk,mainly
the elderly, could have many benefits. However, it should be noted that
Hong Kong is not typical of the rest of the tropics and subtropics. Many
tropical countries face a disease burden from other medical conditions
that is much larger. However, a true understanding of the disease burden
ofinfluenzainrelationtoothermedicalconditionsisimportantinorderto
make rational assessments of resource allocations in health care.
Where Can I Find More Information Online? Fact sheets are available
about various aspects of influenza from the Web site of the World Health
Organization, which takes a global overview of the impact of the disease:
http://www.who.int/topics/influenza/en
There are many health Web sites aimed at patients that provide basic
information about influenza. Some examples are:
http://www.niaid.nih.gov/publications/cold/sick.pdf
http://www.niaid.nih.gov/factsheets/flu.htm
http://www.cdc.gov/flu
http://jama.ama-assn.org/cgi/content/full/293/8/1024
http://www.bbc.co.uk/health/conditions/flu1.shtml
The Government of the Hong Kong Special Administrative Region has a
Web site that includes facts and figures about health in Hong Kong:
http://www.healthyhk.gov.hk/phisweb/en
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